PMID- 23582921
OWN - NLM
STAT- MEDLINE
DCOM- 20130617
LR  - 20181202
IS  - 1532-1916 (Electronic)
IS  - 1521-6918 (Linking)
VI  - 26
IP  - 6
DP  - 2012 Dec
TI  - Surgery for GEP-NETs.
PG  - 819-31
LID - S1521-6918(13)00031-0 [pii]
LID - 10.1016/j.bpg.2012.12.005 [doi]
AB  - Surgery is the only treatment that may cure the patient with 
      gastroentero-pancreatic (GEP) neuroendocrine tumours (NET) and neuroendocrine 
      carcinomas (NEC) and should always be considered as first line treatment if R0/R1 
      resection can be achieved. The surgical and interventional procedures for GEP-NET 
      are accordingly described below. Life-long follow-up should be performed in 
      almost all patients at a specialized NET center.
CI  - Copyright (c) 2013 Elsevier Ltd. All rights reserved.
FAU - Knigge, Ulrich
AU  - Knigge U
AD  - Department of Gastrointestinal Surgery C, Neuroendocrine Tumor Centre of 
      Excellence, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 
      ulrich.knigge@rh.regionh.dk
FAU - Hansen, Carsten Palnaes
AU  - Hansen CP
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Netherlands
TA  - Best Pract Res Clin Gastroenterol
JT  - Best practice & research. Clinical gastroenterology
JID - 101120605
SB  - IM
MH  - Appendiceal Neoplasms/pathology/surgery
MH  - Duodenal Neoplasms/pathology/surgery
MH  - Humans
MH  - Intestinal Neoplasms/pathology/*surgery
MH  - Intestine, Small
MH  - Liver Neoplasms/secondary/therapy
MH  - Neuroendocrine Tumors/pathology/*surgery
MH  - Pancreatic Neoplasms/pathology/*surgery
MH  - Stomach Neoplasms/pathology/*surgery
EDAT- 2013/04/16 06:00
MHDA- 2013/06/19 06:00
CRDT- 2013/04/16 06:00
PHST- 2012/11/19 00:00 [received]
PHST- 2012/12/27 00:00 [accepted]
PHST- 2013/04/16 06:00 [entrez]
PHST- 2013/04/16 06:00 [pubmed]
PHST- 2013/06/19 06:00 [medline]
AID - S1521-6918(13)00031-0 [pii]
AID - 10.1016/j.bpg.2012.12.005 [doi]
PST - ppublish
SO  - Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):819-31. doi: 
      10.1016/j.bpg.2012.12.005.